Xtant Medical (XTNT) EBITDA (2010 - 2026)
Xtant Medical (XTNT) EBITDA from Jun 30, 2010 to Mar 31, 2026. The TTM Xtant Medical (XTNT) EBITDA is $7.98M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Xtant Medical (XTNT) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 5 Years TTM | +27.48% |
Annual EBITDA change of Xtant Medical (XTNT)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$2.39M | -119.10% |
| 2025 | $13M | -259.36% |
| 2024 | -$7.85M | +12.46% |
| 2023 | -$6.98M | +27.84% |
| 2022 | -$5.46M | +116.67% |
| 2021 | -$2.52M | -289.47% |
| 2020 | $1.33M | +49.44% |
| 2019 | $890K | -101.66% |
| 2018 | -$53M | +81.82% |
| 2017 | -$29M | +9706.67% |
| 2016 | -$300K | -95.83% |
| 2015 | -$7.19M | +35.40% |
| 2014 | -$5.31M | -35.64% |
| 2013 | -$8.25M | +98.32% |
| 2012 | -$4.16M | -27.02% |
| 2011 | -$5.70M | -28.12% |
| 2010 | -$7.93M | N/A |
Comparison Xtant Medical (XTNT) five years EBITDA CAGR with competitors
Xtant Medical (XTNT) five years EBITDA CAGR is 27.42%.